Citation Impact
Citing Papers
Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells
2015 Science
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
Lung-resident tissue macrophages generate Foxp3+ regulatory T cells and promote airway tolerance
2013
Macrophages in Allergic Asthma: Fine-Tuning Their Pro- and Anti-Inflammatory Actions for Disease Resolution
2011
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
2018 Standout
Inference and analysis of cell-cell communication using CellChat
2021 Standout
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Wnt5a is elevated in heart failure and affects cardiac fibroblast function
2017
The many paths to asthma: phenotype shaped by innate and adaptive immunity
2010
Nucleotide signalling during inflammation
2014 StandoutNature
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension
2009
A Potential Role for P2X 7 R in Allergic Airway Inflammation in Mice and Humans
2010
Atopic dermatitis
2015 Standout
Pulmonary Veno-Occlusive Disease
2008
Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis
2014 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease
2009
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Cellular and molecular pathobiology of pulmonary arterial hypertension
2004 Standout
Hypoxia Inducible-Factor1α Regulates the Metabolic Shift of Pulmonary Hypertensive Endothelial Cells
2010
Systemic sclerosis
2017 Standout
The prognostic impact of thyroid function in pulmonary hypertension
2016
Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension
2010
The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity
2013
Tissue-based class control: the other side of tolerance
2011
Early detection of pulmonary arterial hypertension
2014
An Atlas of Human Regulatory T Helper-like Cells Reveals Features of Th2-like Tregs that Support a Tumorigenic Environment
2017
The sentinel role of the airway epithelium in asthma pathogenesis
2011
Asthma
2017 Standout
Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma
2010
Innate Immunity and Asthma Risk in Amish and Hutterite Farm Children
2016 Standout
The molecular basis of the host response to lipopolysaccharide
2009
Adipokines in inflammation and metabolic disease
2011 Standout
Interleukin-21-Producing CD4+ T Cells Promote Type 2 Immunity to House Dust Mites
2015
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Macrophages in Tissue Repair, Regeneration, and Fibrosis
2016 Standout
Programming dendritic cells to induce TH2 and tolerogenic responses
2010
EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension
2013
Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study
2017
Protection from asthma in a high-risk birth cohort by attenuated P2X7 function
2012
Cellular and Molecular Basis of Pulmonary Arterial Hypertension
2009
The immunology of asthma
2014
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
2016 Standout
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
IL-33 and ST2 in Atopic Dermatitis: Expression Profiles and Modulation by Triggering Factors
2012
Activated glycoprotein A repetitions predominant (GARP)–expressing regulatory T cells inhibit allergen-induced intestinal inflammation in humanized mice
2015
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
The Metabolic Basis of Pulmonary Arterial Hypertension
2014
Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study
2017
Conventional and Monocyte-Derived CD11b+ Dendritic Cells Initiate and Maintain T Helper 2 Cell-Mediated Immunity to House Dust Mite Allergen
2013
Asthma phenotypes: the evolution from clinical to molecular approaches
2012 Standout
Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice
2009
Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases
2007
Remodeling in Asthma
2009
Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension
2014 Nobel
Macrophage plasticity and polarization: in vivo veritas
2012 Standout
Pulmonary Hypertension Associated with Myeloproliferative Disorders: A Retrospective Study of Ten Cases
2007
Airway Mucus Function and Dysfunction
2010 Standout
Pulmonary veno-occlusive disease
2008
Iron deficiency is common in idiopathic pulmonary arterial hypertension
2010
Pulmonary Arterial Hypertension: A Rare Complication of Primary Sjögren Syndrome
2007
Genetics and Genomics of Pulmonary Arterial Hypertension
2013
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
Protective and pathogenic functions of macrophage subsets
2011 Standout
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome
2017
Mechanisms of disease: pulmonary arterial hypertension
2011
Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature
2014
The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
2008 StandoutNobel
Levels of target activation predict antifibrotic responses to tyrosine kinase inhibitors
2013
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
2020 Standout
T cell homing to epithelial barriers in allergic disease
2012
Immunosuppressive therapy in lupus‐ and mixed connective tissue disease–associated pulmonary arterial hypertension: A retrospective analysis of twenty‐three cases
2008
Chronic thromboembolic pulmonary hypertension
2014
Barrier Epithelial Cells and the Control of Type 2 Immunity
2015
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
NADPH oxidase in the vasculature: Expression, regulation and signalling pathways; role in normal cardiovascular physiology and its dysregulation in hypertension
2019
Cerium oxide nanoparticles attenuate monocrotaline induced right ventricular hypertrophy following pulmonary arterial hypertension
2014
Targeting Energetic Metabolism
2011
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Digoxin inhibits development of hypoxic pulmonary hypertension in mice
2012 StandoutNobel
The role of chemokines and chemokine receptors in pulmonary arterial hypertension
2019
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Pulmonary Arterial Hypertension
2006
Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection
2011 StandoutNobel
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Disease Tolerance as a Defense Strategy
2012 StandoutScience
CSF-1–Dependent Red Pulp Macrophages Regulate CD4 T Cell Responses
2011 StandoutNobel
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
Regulatory roles of IL-10–producing human follicular T cells
2019 StandoutNobel
A natural protective function of invariant NKT cells in a mouse model of innate‐cell‐driven lung inflammation
2010
Inflammation and metabolism in tissue repair and regeneration
2017 StandoutScience
Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor–, granulocyte-macrophage colony-stimulating factor–, and interleukin-3–expressing NOD-SCID IL2Rγnull humanized mice
2011 StandoutNobel
Signaling and Functions of Angiopoietin-1 in Vascular Protection
2006
Top-down design of protein architectures with reinforcement learning
2023 StandoutScienceNobel
Lung Dendritic Cells in Respiratory Viral Infection and Asthma: From Protection to Immunopathology
2012
Predictors of Outcome in Chronic Thromboembolic Pulmonary Hypertension
2007
Works of Frédéric Perros being referenced
miR-223 reverses experimental pulmonary arterial hypertension
2015
Increased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension
2011
Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension
2006
Role of Endothelium-derived CC Chemokine Ligand 2 in Idiopathic Pulmonary Arterial Hypertension
2007
Pulmonary veno-occlusive disease
2016
Platelet-derived Growth Factor Expression and Function in Idiopathic Pulmonary Arterial Hypertension
2008
Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases
2007
Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease
2015
Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension
2010
Inflammation in pulmonary hypertension: what we know and what we could logically and safely target first
2014
Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease
2017
House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells
2009
Tertiary lymphoid organs in infection and autoimmunity
2012
Nuclear Factor κ-B Is Activated in the Pulmonary Vessels of Patients with End-Stage Idiopathic Pulmonary Arterial Hypertension
2013
Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC‐derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation
2009
Current Insights on the Pathogenesis of Pulmonary Arterial Hypertension
2005
Chemotherapy-Induced Pulmonary Hypertension
2014
The Role of Inflammation and Autoimmunity in the Pathophysiology of Pulmonary Arterial Hypertension
2011
Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension
2006
Inflammation in Pulmonary Arterial Hypertension
2012
Inflammation in pulmonary arterial hypertension
2003
Dysregulated Renin–Angiotensin–Aldosterone System Contributes to Pulmonary Arterial Hypertension
2012
C-Kit–Positive Cells Accumulate in Remodeled Vessels of Idiopathic Pulmonary Arterial Hypertension
2011
Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension
2019
Mitomycin-Induced Pulmonary Veno-Occlusive Disease
2015
Bromodomain and extra‐terminal protein mimic JQ1 decreases inflammation in human vascular endothelial cells: Implications for pulmonary arterial hypertension
2016